News
Modern Retina provides ophthalmology professionals with the latest advancements, research, and expert insights in retinal care to improve patient outcomes.
In RESTORE (NCT04945772), a randomized, multicenter, sham-controlled phase 2 clinical trial of 27 patients with severe vision loss from advanced RP, no better than logMAR +1.9 (20/1600 Snellen ...
An Indonesian study of the characteristics of the retinal vasculature found that the retinal vessel tortuosity (VT) was significantly higher and the fractal dimension (FD) was significantly lower in ...
The gift will be used to treat and potentially cure eye diseases like macular degeneration and glaucoma, increase focus on basic science, and harness artificial intelligence to revolutionize vision ...
In a recent study, the researchers suggested that targeting the circuits responsible for visual acuity may be necessary in achieving optimal recovery of visual function and could aid in the ...
Catch up on this week's highlights in retina. Newsletter. Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Jay Chhablani, MD, from the University of Pittsburgh Medical Center's Vision Institute discusses 3D choroidal vessel segmentation technology. Using advanced Plex elite Zeiss swept-source OCT imaging, ...
VG801 is a dual AAV gene therapy that leverages mRNA trans-splicing via the vgRNA REVeRT and vgAAV platforms to deliver the full-length ABCA4 gene for Stargardt disease and related retinal disorders.
Gore recently launched its silicone-free GORE IMPROJECT Plunger for 0.5-mL pre-filled syringes for the delivery of ophthalmic drugs. W. L. Gore and associates (Gore) announced the launch of its ...
Hello, and welcome to this video series sponsored by Bayer. I’m Professor Varun Chaudhary from McMaster University. In this video, we’ll focus on key insights from the pivotal trials for EYLEA 8 mg, ...
The Retina World Congress 2025, led by President Barry Kuppermann, represents a pivotal moment in ophthalmological innovation, bringing together international retina specialists to discuss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results